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A contribution submitted recently (Loewenthal, 1) stated that sodium para-aminoben
zoate (PABA) had at that time produced good results in suppressing the manifestations o'
eczema and atopic dermatitis. Since then I have seen Weiner's (2) preliminary report on the
use of PABA in 16 cases of atopie dermatitis, and as my own results confirm his it seems
timely to submit this report on the short-term effects of PABA, not only in ato pie dermatitis,
but in some forms of eczema. A full report, the second of a series on Chemotherapy in Eczema-
Dermatitis, is in preparation and will embody an analysis of response in various forms of
eczema-dermatitis, as well as observations on the effect of administration of PABA on
patch-test results.
Weiner states that "there is as yet no rationale for this therapy", and that it was tried
because of the marked reduction of the inflammatory infiltrate in the lesions of lupus ery-
thematosus in patients treated with PABA. My own approach was the following:
(1). Sulfonamides, especially sulfapyridine, act as suppressive agents in many cases of
dermatitis herpetiformis.
(2). According to Gordon and Loewenthal (3) many cases of "chronic endogenous eczema"
seem to be variants of dermatitis herpetiformis and respond to sulfapyridine therapy.
(3). The manifestations of auto-sensitization eczema may be indistinguishable from
"chronic endogenous eczema" and respond equally to sulfapyridine.
(4). The search for a more efficient and less toxic agent than sulfapyridine should he guided
by the fact that many sulfonamides exert some effect in these conditions, though sul-
fapyridine is admittedly the best. The search was therefore directed to analogues of
the "sulfa" radicle, rather than the a-aminopyridines, which had proved disappointing.
(5). Para-aminobenzoic acid is chemically similar to the "sulfa" group. Sulfanilamide also
acts as a competitive analogue to PABA in bacteria, and this is generally accepted as
the explanation of its baeteriostatic properties (Hawking and Lawrence, 4).
(6). PABA was therefore tried in my cases on the bases of chemical and biologic analogy.
Results. Cases of atopic dermatitis have shown the same type of improvement as have
Weiner's. 37 cases of various forms of eczema have responded still more dramatically, and
results with PABA are far more striking than those with sulfapyridine. In attempting to
determine a standard dosage PABA has been given in doses varying from 1.5 to 4.0 grams
4 times daily. Unpleasant side effects have so far not been seen in 55 cases treated in this
way.
CASE REPORTS
1. Mrs. 0. E. age 28. White. The condition began in November, 1948 as a scaly patch on
the left instep with outlying vesicles, and this was shortly followed by an eczema of the
fingers, Seen by me for the first time on March 15, 1950: The foot had cleared many months
before on anti-fungal treatment, but the eruption on the hands was still present. This was
treated for seven months with local applications of Vioform for secondary sepsis, avoidance
of soap and water, a course of sulfapyridine (1 tablet three times a day) for two weeks and
a course of Fowler's solution (3 minims three times a day) for two weeks.
No real change beyond slight fluctuations had been apparent in November, by which
time she had been unable to use her hands for any domestic chores for exactly two years.
Bandages had been worn constantly. There was a large eczematous area involving all fingers
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and the clorsum of the left hand. Two nummular eczematous plaques were present on the
left forearm, one on the right middle finger and four on the right forearm. All lesions were
raised, irritable and crusting. PABA given by mouth, 2 gms. four times daily, on Nov. 13,
1950. On November 17, 1950, itching had ceased after 24 hours and, on examination, all
lesions had epithelialized and no new areas were affected. This improvement was very dra-
matic and the dosage was reduced to 1.5 gms. four times daily. Ou November 21, 1950, all
lesions were completely healed and, in those where a slight discoloration was not left, very
careful examination was required to see where the lesions had been present one week hefore.
2. Mr. 1?. M. Age 38. While was seen on November 6, 1950 and complaining of an ex-
tremely itchy eruption of both legs, thighs, buttocks and lower trunk. The history did not
reveal any external or internal cause, except for a period of nervous strain. On examination
there was a papular and vesicular grouped eruption, with many excoriations in the above
areas. On November 6, 1950, Sulfapyridine 0.5 gm. four times daily and Fowler's solution
4 m. three times daily were prescribed. On November 10, 1950, the irritation was somewhat
improved. On November 14, 1950, no further improvement was noted and the patient states
the itching has become more severe. PABA 2 gms. four times daily was prescribed. On
November 17, 1950, the patient reported complete relief after 24 hours, and has slept nor-
mally for the first time in 2 weeks. The eruption was faintly erythematous and slightly scal-
ing. No fresh scratch marks were seen. PABA was reduced to 2 gms. three times daily. No
local treatment had been prescribed. The patient was free of the eruption on a dose of 6
gms. daily except for one short episode of itching with a flare-up following an alcoholic
drink.
Corn?nent. These results show an immediate suppressive action by PABA. They do not
constitute a cure any more than does the administration of anti-histaminics in urticaria.
The fact that results in eczematous eruptions are superior to those in atopic dermatitis may
support the view that the latter disease has an eczematous and an urticarial component.
If this view is correct the simultaneous administration of PABA and an anti-histaminic
might improve therapeutic results in atopic dermatitis.
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